31 Mar 2023
Assets39.48
Total Income89.38
EBITDA11.03
Profit After Tax7.60
NET Worth8.37
Reserves and Surplus8.22
Total Borrowing19.87
At a glance
Updated 2026-08-24The shares listed at ₹172.10, a 27.48% move from the issue price. KRM Ayurveda is a SME IPO with an issue size of ₹77.49 crore, proposed for listing on NSE SME. The offer opens on 21st Jan 2026 and closes on 23rd Jan 2026. The issue structure includes a fresh issue of ₹69.74 crore. The current listing schedule points to 29th Jan 2026.
Issue details
Listing atNSE SME
Issue typeBook Build Issue
Issue size₹77.49 Cr
Fresh issue₹69.74 Cr
Face value₹10
Price band₹128.00–₹135.00
Allotment27th Jan 2026
Listing29th Jan 2026
Listing performance
Full performance ↗Issue price₹135.00
Listing price₹172.10
Current price—
Listing gain27.48%
Current return—
Price progressionIssue → Listing → Current
Grey market
GMP page ↗Latest GMP₹22.50
GMP / upper price16.67%
Est. listing₹157.50
GMP is unofficial sentiment data, not an exchange price.
Timeline
Opens21st Jan 2026
Closes23rd Jan 2026
Allotment27th Jan 2026
Refund28th Jan 2026
Demat28th Jan 2026
Listing29th Jan 2026
Subscription demand
Full bidding ↗Total74.27×
Lot size
| Investor | Lots | Shares | Amount |
|---|---|---|---|
| Minimum Bid | 1 | 2000 | ₹270,000 |
Company
Use of proceeds
| Object | Amount |
|---|---|
| Capital Expenditure for Construction and Development of Telemedicine Operational Facilities | ₹13.67 Cr |
| Purchase of CRM Software and Hardware Infrastructure | ₹1.42 Cr |
| Human Resources | ₹5.44 Cr |
| Repayment/Prepayment of loan | ₹12.50 Cr |
| Working Capital Requirement | ₹22.90 Cr |
| General Corporate Purposes | ₹10.00 Cr |
| Issue Expenses | ₹11.57 Cr |
| Total | ₹77.49 Cr |
Financials
Full financials ↗31 Mar 2024
Assets43.91
Total Income67.57
EBITDA7.34
Profit After Tax3.41
NET Worth11.78
Reserves and Surplus11.63
Total Borrowing23.18
31 Mar 2025
Assets66.79
Total Income76.95
EBITDA19.11
Profit After Tax12.10
NET Worth23.88
Reserves and Surplus23.73
Total Borrowing31.20
30 Sep 2025
Assets78.12
Total Income48.65
EBITDA12.83
Profit After Tax8.14
NET Worth36.13
Reserves and Surplus20.61
Total Borrowing25.07
Trend chart₹ crore
KPIs
| KPI | Mar 31, 2025 | Sep 30, 2025 |
|---|---|---|
| ROE | 67.86% | 21.84% |
| ROCE | 43.33% | 21.84% |
| Debt / Equity | 1.31% | 0.69% |
| RoNW | 67.86% | 21.84% |
| PAT Margin | 15.80% | 16.83% |
| EBITDA Margin | 24.96% | 26.54% |
| Price to Book Value | 0.08 | 5.27 |
Valuation & shareholding
Pre-IPO EPS7.79
Post-IPO EPS5.69
Pre-IPO P/E17.32
Post-IPO P/E23.73
Promoter holding pre92.16%
Promoter holding post67.28%
Market cap₹287.02 Cr.
Issue expenses
| Expense | Amount |
|---|---|
| Capital Expenditure for Construction and Development of Telemedicine Operational Facilities | ₹13.67 Cr |
| Purchase of CRM Software and Hardware Infrastructure | ₹1.42 Cr |
| Human Resources | ₹5.44 Cr |
| Repayment/Prepayment of loan | ₹12.50 Cr |
| Working Capital Requirement | ₹22.90 Cr |
| General Corporate Purposes | ₹10.00 Cr |
| Issue Expenses | ₹11.57 Cr |
| Total | ₹77.49 Cr |
Registrar & lead managers
Registrar
Skyline Financial Services Pvt.Ltd.Lead managers
- Location
Offer documents
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-08-24.